196 related articles for article (PubMed ID: 29764482)
41. Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use.
Coutinho AD; Gandhi K; Fuldeore RM; Landsman-Blumberg PB; Gandhi S
J Opioid Manag; 2018; 14(2):131-141. PubMed ID: 29733099
[TBL] [Abstract][Full Text] [Related]
42. Healthcare utilization and costs associated with treatment for opioid dependence.
Shah A; Duncan M; Atreja N; Tai KS; Gore M
J Med Econ; 2018 Apr; 21(4):406-415. PubMed ID: 29320915
[TBL] [Abstract][Full Text] [Related]
43. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
Webster BS; Verma SK; Gatchel RJ
Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.
Zedler B; Xie L; Wang L; Joyce A; Vick C; Kariburyo F; Rajan P; Baser O; Murrelle L
Pain Med; 2014 Nov; 15(11):1911-29. PubMed ID: 24931395
[TBL] [Abstract][Full Text] [Related]
45. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.
Kirson NY; Shei A; Rice JB; Enloe CJ; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
Pain Med; 2015 Jul; 16(7):1325-32. PubMed ID: 25929289
[TBL] [Abstract][Full Text] [Related]
46. Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis.
Olufade T; Kong AM; Princic N; Juneau P; Kulkarni R; Zhang K; Datto C
Am Health Drug Benefits; 2017 Apr; 10(2):79-86. PubMed ID: 28626504
[TBL] [Abstract][Full Text] [Related]
47. Post-operative opioid pain management patterns for patients who receive hip surgery.
Cook CE; Rhon DI; Lewis BD; George SZ
Subst Abuse Treat Prev Policy; 2017 Mar; 12(1):14. PubMed ID: 28298221
[TBL] [Abstract][Full Text] [Related]
48. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
49. Emergency Providers' Opioid Prescribing Behaviors Among Medicare Part D Beneficiaries in North Carolina, 2013-2014: Medication Utilization and Costs.
Williams B; Mospan G; Seabock R; Gillette C; DeGeeter M
N C Med J; 2018; 79(3):143-148. PubMed ID: 29735614
[No Abstract] [Full Text] [Related]
50. The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain.
Ivanova JI; Birnbaum HG; Yushkina Y; Sorg RA; Reed J; Merchant S
J Opioid Manag; 2013; 9(4):239-54. PubMed ID: 24353017
[TBL] [Abstract][Full Text] [Related]
51. Opioid Use After ICU Admission Among Elderly Chronic Opioid Users in Ontario: A Population-Based Cohort Study.
Wang HT; Hill AD; Gomes T; Wijeysundera DN; Pinto R; Scales DC; Fowler R; Wunsch H
Crit Care Med; 2018 Dec; 46(12):1934-1942. PubMed ID: 30222633
[TBL] [Abstract][Full Text] [Related]
52. Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR.
Lin J; Chow W; Kim MS; Rupnow MF
J Med Econ; 2013; 16(5):685-90. PubMed ID: 23441974
[TBL] [Abstract][Full Text] [Related]
53. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
[TBL] [Abstract][Full Text] [Related]
54. The risks and costs of multiple-generic substitution of topiramate.
Duh MS; Paradis PE; Latrémouille-Viau D; Greenberg PE; Lee SP; Durkin MB; Wan GJ; Rupnow MF; LeLorier J
Neurology; 2009 Jun; 72(24):2122-9. PubMed ID: 19528520
[TBL] [Abstract][Full Text] [Related]
55. Timing of physical therapy consultation on 1-year healthcare utilization and costs in patients seeking care for neck pain: a retrospective cohort.
Horn ME; Fritz JM
BMC Health Serv Res; 2018 Nov; 18(1):887. PubMed ID: 30477480
[TBL] [Abstract][Full Text] [Related]
56. Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role of non-hematologic characteristics and baseline chronic opioid dose.
Carroll CP; Cichowitz C; Yu T; Olagbaju YO; Nelson JA; Campbell T; Lanzkron S
Am J Hematol; 2018 Sep; 93(9):1127-1135. PubMed ID: 30035821
[TBL] [Abstract][Full Text] [Related]
57. Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use-A health insurance claims analysis.
Burgstaller JM; Held U; Signorell A; Blozik E; Steurer J; Wertli MM
PLoS One; 2020; 15(9):e0238285. PubMed ID: 32925928
[TBL] [Abstract][Full Text] [Related]
58. Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study.
Muratov S; Lee J; Holbrook A; Costa A; Paterson JM; Guertin JR; Mbuagbaw L; Gomes T; Khuu W; Tarride JE
BMC Geriatr; 2018 Nov; 18(1):262. PubMed ID: 30382828
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and characteristics associated with high dose opioid users among older adults.
Musich S; Wang SS; Slindee L; Kraemer S; Yeh CS
Geriatr Nurs; 2019; 40(1):31-36. PubMed ID: 29903513
[TBL] [Abstract][Full Text] [Related]
60. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019.
Thornton JD; Varisco T; Bhatt M Econ P; Olateju O; Shrestha M; Shen C
J Occup Environ Med; 2024 Mar; 66(3):226-233. PubMed ID: 38151973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
